你即將離開本站

並前往https://clinicaltrials.gov/ct2/show/NCT04816643

A Phase 1/2/3 Study to Evaluate the Safety, Tolerability

Percentage of participants in Phase 2/3 reporting serious adverse events [ Time Frame: from Dose 1 through 6 months after the last dose ].

確定！ 回上一頁

查詢 「2 months」的人也找了：

  1. 2 months中文
    2.
  2. 2-month or 2-months
    3.
  3. months old中文
    4.
  4. 2 months later
    5.
  5. 2 months old
    6.
  6. 2 months ago
    7.
  7. Two months
    8.
  8. Milestones
    9.